A consensus statement: meningococcal disease among infants, children and adolescents in Latin America
Author
dc.contributor.author
Rüttimann, Ricardo Walter
Author
dc.contributor.author
Gentile, Ángela
es_CL
Author
dc.contributor.author
Macías Parra, Mercedes
es_CL
Author
dc.contributor.author
Sáez Llorens, Xavier
es_CL
Author
dc.contributor.author
Palazzi Safadi, Marco Aurelio
es_CL
Author
dc.contributor.author
Santolaya de Pablo, María Elena
es_CL
Admission date
dc.date.accessioned
2014-10-14T19:40:08Z
Available date
dc.date.available
2014-10-14T19:40:08Z
Publication date
dc.date.issued
2014
Cita de ítem
dc.identifier.citation
The Pediatric Infectious Disease Journal • Volume 33, Number 3, March 2014
en_US
Identifier
dc.identifier.issn
0891-3668/14/3303-0284
Identifier
dc.identifier.other
DOI: 10.1097/INF.0000000000000228
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/129326
General note
dc.description
Artículo de publicación ISI
en_US
Abstract
dc.description.abstract
Invasive meningococcal disease is a serious infection that occurs
worldwide. Neisseria meningitidis remains one of the leading causes of bacterial
meningitis in all ages. Despite the availability of safe and effective
vaccines against invasive meningococcal disease, few countries in Latin
America implemented routine immunization programs with these vaccines.
The Americas Health Foundation along with Fighting Infectious Disease in
Emerging Countries recently sponsored a consensus conference. Six experts
in infectious diseases from across the region addressed questions related to
this topic and formulated the following recommendations: (1) standardized
passive and active surveillance systems should be developed and carriage
studies are mandatory; (2) a better understanding of the incidence, case
fatality rates and prevalent serogroups in Latin America is needed; (3) countries
should make greater use of the polymerase chain reaction assays to
improve the sensitivity of diagnosis and surveillance of invasive meningococcal
disease; (4) vaccines with broader coverage and more immunogenicity
are desirable in young infants; (5) prevention strategies should include
immunization of young infants and catch-up children and adolescents and
(6) because of the crowded infant immunization schedule, the development
of combined meningococcal vaccines and the coadministration with other
infant vaccines should be explored.
en_US
Patrocinador
dc.description.sponsorship
This study was supported by unrestricted grant from Americas Health Foundation.